It’s this inflammation of the lining of your nose that produces the telltale stuffiness sensation of chronic nasal congestion ...

Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP –– Commenced startup for a Phase 2 clinical trial in ...

IL-5 is present at high levels in nasal polyp tissue. IL-5 inhibitors play ... The only question is “Will you get into the right stocks early when their growth potential is greatest?” ...

Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review. Keywords: Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), ...

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...

The Simponi biosimilar, AVT05, has shown positive top-line results in patients with moderate to severe rheumatoid arthritis.

Insmed Incorporated ( NASDAQ: INSM) Q3 2024 Earnings Conference Call October 31, 2024 8:00 AM ET Bryan Dunn – Head of Investor Relations Will Lewis – Chair and Chief Executive Officer Sara Bonstein – ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A ...

The bottle was right in front of her, but she was frozen ... Pharma – also liked that the study showed Neffy to be effective for people experiencing nasal polyps and congestion, since it’s delivered ...

The bottle was right in front of her ... that the study showed Neffy to be effective for people experiencing nasal polyps and congestion, since it’s delivered through the nose.

Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q3 2024 earnings call. [Operator ...

You should not receive a "live vaccine" right before and during treatment with DUPIXENT ... chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, or chronic ...